Hims & Hers Announces Major Share Repurchase Initiative

The telehealth provider Hims & Hers has unveiled a substantial new capital return initiative, authorizing a share buyback program valued at $250 million. This announcement comes immediately following the rapid completion of the company’s previous $100 million repurchase plan, signaling strong management confidence in the company’s valuation and future prospects.

Accelerated Buyback Execution Precedes New Authorization

Market observers are noting the exceptional speed with which Hims & Hers executed its previous repurchase authorization. The company had initially approved a $100 million buyback program in July 2024. Between October and November 2025, the company fully utilized this authorization, with a particularly concentrated repurchase activity occurring between November 1st and 7th, during which approximately 1.33 million shares were acquired for $55.5 million.

The immediate transition to a significantly larger $250 million program demonstrates the company’s commitment to returning capital to shareholders. The newly authorized repurchase initiative has a three-year duration, extending through November 2028, providing management with substantial flexibility to execute purchases opportunistically.

Strategic Rationale Behind Aggressive Capital Return

This substantial capital allocation toward share repurchases represents a clear statement from management that they believe the company’s shares are undervalued at current market prices. By systematically reducing the number of outstanding shares, the company aims to increase earnings per share and create upward pressure on the stock through reduced supply.

Should investors sell immediately? Or is it worth buying Hims & Hers?

Hims & Hers shares have recently been trading around $35, reaching highs near this level, with the company’s market capitalization standing at approximately $7.9 billion. This represents a notable appreciation from the previous year’s level of $29 per share.

The company maintains multiple execution methods for these repurchases, including open market transactions, privately negotiated agreements, and rule-based trading plans under Rule 10b5-1. This strategic flexibility allows the company to support the share price during periods of market volatility while simultaneously optimizing long-term shareholder value.

The seamless transition between repurchase programs and the substantial increase in authorization size sends a powerful message about management’s conviction in the company’s growth trajectory and their belief that significant upside potential remains in the current valuation.